Navigation Links
Advanced Health Media, Inc. Announces New SVP Product Delivery
Date:9/9/2011

NEW PROVIDENCE, N.J., Sept. 9, 2011 /PRNewswire/ -- Advanced Health Media (AHM), the leading supplier of speaker program and commercial compliance management solutions for the pharmaceutical industry, has named Paul O'Toole as its new Senior Vice President of Product Delivery, effective immediately. Paul brings over 20 years of experience building and managing healthcare technology service organizations, including software and product development, implementation, professional services, and customer support.

"Paul will lead AHM's Product Delivery organization in Chesapeake, VA, and serve as a member of the AHM executive team," said James Burgess, AHM Chief Executive Officer. "He has an excellent background for leading AHM's technology enabled product and service offerings business. I have worked with Paul in the past and have complete confidence in his ability to help our organization reach the next level of product and service delivery."

Most recently, Paul was Senior Vice President of Operations at Healthland, a leading developer of rural hospital management software. Paul has also served as Vice President and Divisional General Manager of Mediware Information Systems Inc. and before that Global Services & Support Director of the Health Information Systems division of 3M. Prior to 3M, Paul held various management and executive positions at both VHA and IBM Corporation.

"I'm excited to join the AHM team. This organization is investing in more customer centric products and services using the most current technology platforms and I will be part of driving continued advancements in the business," adds Paul.

Paul received his Bachelor of Science Engineering degree at Northeastern University. He is also a certified Six Sigma Black Belt.

About AHM

Advanced Health Media, located in New Providence, NJ, provides technology enabled services specifically designed to drive compliance for the highly regulated pharmaceutical and life sciences industries. AHM's proprietary systems are used by many of the top pharmaceutical companies in the U.S. and by tens of thousands of pharmaceutical sales representatives and managers. AHM is a Microsoft Certified Partner company. For more information, please visit www.ahmdirect.com.


'/>"/>
SOURCE Advanced Health Media
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Lilly and Company (NYSE: LLY ) today ... at the 9 th Clinical Trials on Alzheimer,s ... meet the primary endpoint in the EXPEDITION3 clinical trial, ... dementia due to Alzheimer,s disease (AD), and Lilly will ... of mild dementia due to AD. ...
(Date:12/8/2016)... DUBLIN , Dec 8, 2016 Research ... Electrodes Market Analysis and Trends - Adhesion Type, Application, Usability - ... ... The Global Cardiology Electrodes Market is poised to grow at a ... prominent trends that the market is witnessing include advancements in extracellular ...
(Date:12/8/2016)... 8, 2016   TriNetX , the health ... Hospital signed a membership agreement to join ... of new cures. The TriNetX network ... million patients globally, biopharmaceutical companies and contract research ... protocol design, site selection, patient recruitment, and collaborative ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... The ... the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. ... safety. Only a few hospitals and facilities have earned this distinction. This is ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ ... announced the first national #QuackGivesBack campaign which supported local breast cancer organizations during ... franchise-wide Quack Gives Back initiative, and we’re very pleased with the ...
(Date:12/8/2016)... Pa. (PRWEB) , ... December 08, 2016 , ... ... Medicine Southern Chester County, a Property owned by an affiliate of Seavest, has ... square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was named ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... CURE Media ... centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat ... the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
Breaking Medicine News(10 mins):